DK1408953T3 - Carbamatforbindelser til anvendelse til forebyggelse eller behandling af bipolær sygdom - Google Patents

Carbamatforbindelser til anvendelse til forebyggelse eller behandling af bipolær sygdom

Info

Publication number: DK1408953T3
Authority: DK; Denmark
Prior art keywords: bipolar disorder; prevention; treatment; phenyl; alkyl
Prior art date: 2001-02-27

Application number

DK02724984T

Other languages

Danish (da)

English (en)

Inventor

Carlos R Plata-Salaman

Boyu Zhao

Roy E Twyman

Yong Moon Choi

Robert Gordon

Original Assignee

Ortho Mcneil Pharm Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-02-27

Filing date

2002-02-21

Publication date

2006-08-21

2002-02-21 Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc

2006-08-21 Application granted granted Critical

2006-08-21 Publication of DK1408953T3 publication Critical patent/DK1408953T3/da

Links

208000020925 Bipolar disease Diseases 0.000 title abstract 2
150000004657 carbamic acid derivatives Chemical class 0.000 title 1
230000002265 prevention Effects 0.000 title 1
125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 3
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 3
125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 abstract 1
WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 abstract 1
ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 1
PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 1
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 1
229910052794 bromium Inorganic materials 0.000 abstract 1
229910052801 chlorine Inorganic materials 0.000 abstract 1
239000000460 chlorine Substances 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
125000004093 cyano group Chemical group *C#N 0.000 abstract 1
229910052731 fluorine Inorganic materials 0.000 abstract 1
239000011737 fluorine Substances 0.000 abstract 1
229910052736 halogen Inorganic materials 0.000 abstract 1
125000005843 halogen group Chemical group 0.000 abstract 1
150000002367 halogens Chemical group 0.000 abstract 1
229910052739 hydrogen Inorganic materials 0.000 abstract 1
239000001257 hydrogen Substances 0.000 abstract 1
229910052740 iodine Inorganic materials 0.000 abstract 1
239000011630 iodine Substances 0.000 abstract 1
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
125000001424 substituent group Chemical group 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants

Landscapes

Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
General Chemical & Material Sciences (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Emergency Medicine (AREA)
Pain & Pain Management (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Pyridine Compounds (AREA)
Hydrogenated Pyridines (AREA)

DK02724984T 2001-02-27 2002-02-21 Carbamatforbindelser til anvendelse til forebyggelse eller behandling af bipolær sygdom DK1408953T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US27168101P	2001-02-27	2001-02-27
US10/081,766 US6562867B2 (en)	2001-02-27	2002-02-21	Carbamate compounds for use in preventing or treating bipolar disorder

Publications (1)

Publication Number	Publication Date
DK1408953T3 true DK1408953T3 (da)	2006-08-21

Family

ID=26765948

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK02724984T DK1408953T3 (da)	2001-02-27	2002-02-21	Carbamatforbindelser til anvendelse til forebyggelse eller behandling af bipolær sygdom

Country Status (26)

Country	Link
US (1)	US6562867B2 (cs)
EP (1)	EP1408953B1 (cs)
JP (1)	JP4276837B2 (cs)
KR (1)	KR100946944B1 (cs)
CN (1)	CN1250215C (cs)
AT (1)	ATE324108T1 (cs)
BR (1)	BR0207644A (cs)
CA (1)	CA2439475C (cs)
CY (1)	CY1105330T1 (cs)
CZ (1)	CZ20032300A3 (cs)
DE (1)	DE60210976T2 (cs)
DK (1)	DK1408953T3 (cs)
ES (1)	ES2262801T3 (cs)
HU (1)	HUP0303243A3 (cs)
IL (1)	IL157590A0 (cs)
MX (1)	MXPA03007717A (cs)
MY (1)	MY129304A (cs)
NO (1)	NO20033802L (cs)
NZ (1)	NZ527988A (cs)
PL (1)	PL364638A1 (cs)
PT (1)	PT1408953E (cs)
RS (1)	RS50677B (cs)
RU (1)	RU2300372C2 (cs)
TW (1)	TWI250872B (cs)
WO (1)	WO2002067921A1 (cs)
ZA (1)	ZA200307465B (cs)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2002007822A2 (en) *	2000-07-21	2002-01-31	Ortho-Mcneil Pharmaceutical, Inc.	Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
CZ20032311A3 (cs)	2001-02-27	2005-02-16	Ortho-Mcneil Pharmaceutical, Inc.	Karbamátová sloučenina a léčivo pro prevenci a léčení úzkosti
IL157591A0 (en) *	2001-02-27	2004-03-28	Ortho Mcneil Pharm Inc	Carbamate compounds for use in preventing or treating neurodegenerative disorders
PL368164A1 (en)	2001-07-16	2005-03-21	Ortho-Mcneil Pharmaceutical, Inc.	Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
HRP20100304T1 (hr) *	2004-09-16	2010-09-30	Janssen Pharmaceutica Nv	Uporaba 2-fenil-1,2-etanediol-(di)karbamata za liječenje epileptogeneze
AU2006254899B2 (en) *	2005-06-08	2011-11-24	Sk Biopharmaceuticals Co., Ltd.	Treatment of sleep-wake disorders
US20070021501A1 (en) *	2005-07-12	2007-01-25	Twyman Roy E	Methods of treating epileptogenesis
WO2008055022A2 (en) *	2006-10-30	2008-05-08	Janssen Pharmaceutica, N.V.	Carbamate compounds for use in treating depression
CA2667909A1 (en) *	2006-10-31	2008-05-08	Janssen Pharmaceutica N.V.	Treatment of pervasive developmental disorders
US8609849B1 (en)	2010-11-30	2013-12-17	Fox Chase Chemical Diversity Center, Inc.	Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
JP6131341B2 (ja) *	2013-03-12	2017-05-17	バイオ−ファームソリューションズカンパニーリミテッド	フェニルカルバメート化合物及びこれを含む精神疾患の予防又は治療用組成物｛ｐｈｅｎｙｌｃａｒｂａｍａｔｅｃｏｍｐｏｕｎｄａｎｄａｃｏｍｐｏｓｉｔｉｏｎｆｏｒｐｒｅｖｅｎｔｉｎｇｏｒｔｒｅａｔｉｎｇａｐｓｙｃｈｉａｔｒｉｃｄｉｓｏｒｄｅｒｃｏｍｐｒｉｓｉｎｇｔｈｅｓａｍｅ｝
US10195151B2 (en)	2016-09-06	2019-02-05	Jazz Pharmaceuticals International Iii Limited	Formulations of (R)-2-amino-3-phenylpropyl carbamate
JP7208139B2 (ja) *	2016-12-14	2023-01-18	エスケーバイオファーマスティカルズカンパニーリミテッド	双極性障害の予防、軽減又は治療のためのカルバメート化合物の使用
EP3630072A4 (en)	2017-06-02	2021-03-10	Jazz Pharmaceuticals Ireland Limited	METHODS AND COMPOSITIONS FOR TREATMENT OF EXCESSIVE Drowsiness
US10940133B1 (en)	2020-03-19	2021-03-09	Jazz Pharmaceuticals Ireland Limited	Methods of providing solriamfetol therapy to subjects with impaired renal function

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3313692A (en) *	1958-04-21	1967-04-11	Armour Pharma	Method of inducing calming and muscle relaxation with carbamates
US3278380A (en) *	1962-02-06	1966-10-11	Armour Pharma	Methods of calming employing diphenyl hydroxy carbamate compounds
US3265728A (en) *	1962-07-18	1966-08-09	Armour Pharma	Substituted phenethyl carbamates
EP0765327B1 (en) *	1994-06-16	1999-07-21	Pfizer Inc.	Pyrazolo and pyrrolopyridines
US5698588A (en) *	1996-01-16	1997-12-16	Yukong Limited	Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol

2002
- 2002-02-21 CZ CZ20032300A patent/CZ20032300A3/cs unknown
- 2002-02-21 US US10/081,766 patent/US6562867B2/en not_active Expired - Lifetime
- 2002-02-21 NZ NZ527988A patent/NZ527988A/en unknown
- 2002-02-21 ES ES02724984T patent/ES2262801T3/es not_active Expired - Lifetime
- 2002-02-21 MX MXPA03007717A patent/MXPA03007717A/es active IP Right Grant
- 2002-02-21 CA CA2439475A patent/CA2439475C/en not_active Expired - Fee Related
- 2002-02-21 BR BR0207644-6A patent/BR0207644A/pt not_active Application Discontinuation
- 2002-02-21 DK DK02724984T patent/DK1408953T3/da active
- 2002-02-21 PL PL02364638A patent/PL364638A1/xx not_active Application Discontinuation
- 2002-02-21 WO PCT/US2002/005297 patent/WO2002067921A1/en not_active Ceased
- 2002-02-21 IL IL15759002A patent/IL157590A0/xx not_active IP Right Cessation
- 2002-02-21 PT PT02724984T patent/PT1408953E/pt unknown
- 2002-02-21 HU HU0303243A patent/HUP0303243A3/hu unknown
- 2002-02-21 RU RU2003128997/14A patent/RU2300372C2/ru active
- 2002-02-21 AT AT02724984T patent/ATE324108T1/de active
- 2002-02-21 KR KR1020037011296A patent/KR100946944B1/ko not_active Expired - Lifetime
- 2002-02-21 EP EP02724984A patent/EP1408953B1/en not_active Expired - Lifetime
- 2002-02-21 DE DE60210976T patent/DE60210976T2/de not_active Expired - Lifetime
- 2002-02-21 JP JP2002567288A patent/JP4276837B2/ja not_active Expired - Lifetime
- 2002-02-21 CN CNB028089170A patent/CN1250215C/zh not_active Expired - Fee Related
- 2002-02-21 RS YUP-678/03A patent/RS50677B/sr unknown
- 2002-02-27 TW TW091103500A patent/TWI250872B/zh active
- 2002-02-27 MY MYPI20020691A patent/MY129304A/en unknown
2003
- 2003-08-26 NO NO20033802A patent/NO20033802L/no not_active Application Discontinuation
- 2003-09-25 ZA ZA200307465A patent/ZA200307465B/en unknown
2006
- 2006-06-21 CY CY20061100844T patent/CY1105330T1/el unknown

Also Published As

Publication number	Publication date
KR100946944B1 (ko)	2010-03-15
US6562867B2 (en)	2003-05-13
ES2262801T3 (es)	2006-12-01
NO20033802D0 (no)	2003-08-26
CA2439475C (en)	2010-05-18
EP1408953B1 (en)	2006-04-26
HUP0303243A2 (hu)	2004-01-28
ATE324108T1 (de)	2006-05-15
PL364638A1 (en)	2004-12-13
RU2003128997A (ru)	2005-03-20
CZ20032300A3 (cs)	2005-01-12
RU2300372C2 (ru)	2007-06-10
NO20033802L (no)	2003-10-22
CN1250215C (zh)	2006-04-12
RS50677B (sr)	2010-06-30
WO2002067921A1 (en)	2002-09-06
JP2004533415A (ja)	2004-11-04
EP1408953A1 (en)	2004-04-21
IL157590A0 (en)	2004-03-28
HK1063436A1 (en)	2004-12-31
JP4276837B2 (ja)	2009-06-10
CN1505506A (zh)	2004-06-16
BR0207644A (pt)	2004-03-09
DE60210976T2 (de)	2007-05-24
MY129304A (en)	2007-03-30
CY1105330T1 (el)	2010-03-03
CA2439475A1 (en)	2002-09-06
YU67803A (sh)	2006-08-17
US20020198257A1 (en)	2002-12-26
DE60210976D1 (de)	2006-06-01
ZA200307465B (en)	2005-03-17
MXPA03007717A (es)	2005-11-08
NZ527988A (en)	2006-01-27
HUP0303243A3 (en)	2012-07-30
TWI250872B (en)	2006-03-11
PT1408953E (pt)	2006-07-31
KR20030087010A (ko)	2003-11-12

Publication	Publication Date	Title
NO20071921L (no)	2007-06-12	Fremgangsmater for behandling av epileptogenese og epilepsi
MY157373A (en)	2016-06-15	Carbamate compounds for use in preventing or treating movement disorders
MY138156A (en)	2009-04-30	Carbamate compounds for use in preventing or treating neurodegenerative disorders
NO20033802D0 (no)	2003-08-26	Karbamatforbindelser for anvendelse ved forebygging eller behandling av bipolar forstyrrelse
DK1368021T3 (da)	2008-02-11	Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af bipolær sygdom
DK1399144T3 (da)	2006-07-24	Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af angstforstyrrelser
DK1305082T3 (da)	2004-09-13	Carbamatforbindelser til anvendelse til forebyggelse eller behandling af neuropatisk smerte og klynge- eller migrænehovedpine-associeret smerte
DK1408954T3 (da)	2009-10-12	Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af neuropatisk smerte
MY136733A (en)	2008-11-28	Carbamate compounds for use in preventing or treating psychotic disorders